series-c-plus
Stage
1
Investors
About
Innovent Biologics is a China-based biopharmaceutical company focused on the independent research and development of innovative drugs, including ophthalmic drugs, recombinant botulinum toxins, tumor immunotherapies, and pet immunotherapies, with several clinical-stage candidates.
Explore Innovent Biologics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.